ClinVar Miner

Submissions for variant NM_138694.4(PKHD1):c.9705T>A (p.Asn3235Lys)

dbSNP: rs759568939
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000265753 SCV000464039 uncertain significance Autosomal recessive polycystic kidney disease 2018-01-13 criteria provided, single submitter clinical testing This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.
Counsyl RCV000265753 SCV000790717 uncertain significance Autosomal recessive polycystic kidney disease 2017-04-05 criteria provided, single submitter clinical testing
Invitae RCV000265753 SCV001232187 likely benign Autosomal recessive polycystic kidney disease 2024-01-29 criteria provided, single submitter clinical testing
Pars Genome Lab RCV001526423 SCV001736783 uncertain significance Polycystic kidney disease 4 2021-05-18 criteria provided, single submitter clinical testing
Genome-Nilou Lab RCV001526423 SCV001806438 uncertain significance Polycystic kidney disease 4 2021-07-22 criteria provided, single submitter clinical testing
Victorian Clinical Genetics Services, Murdoch Childrens Research Institute RCV001526423 SCV002769166 uncertain significance Polycystic kidney disease 4 2019-08-28 criteria provided, single submitter clinical testing A heterozygous missense variant was identified, NM_138694.3(PKHD1):c.9705T>A in exon 58 of 67 of the PKHD1 gene. This substitution is predicted to create a moderate amino acid change from asparagine to lysine at position 3235 of the protein, NP_619639.3(PKHD1):p.(Asn3235Lys). The asparagine at this position has moderate conservation (100 vertebrates, UCSC), but is not situated in a known functional domain. In silico software predictions of the pathogenicity of this variant are conflicting (Polyphen, SIFT, CADD, Mutation Taster). The variant is present in the gnomAD population database at a frequency of 0.015% (35 heterozygotes, 1 homozygote). The variant has been previously reported as both a VUS (ClinVar) and in a homozygote patient with polycystic kidney disease (Alehabib, E., et al. (2017)). Subsequent analysis of parental samples indicated this variant was maternally inherited. Based on information available at the time of curation, this variant has been classified as a VARIANT of UNCERTAIN SIGNIFICANCE (VUS).
Natera, Inc. RCV000265753 SCV002075537 uncertain significance Autosomal recessive polycystic kidney disease 2018-07-17 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.